These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

308 related articles for article (PubMed ID: 11019931)

  • 41. Addressing the Side Effects of Contemporary Antidepressant Drugs: A Comprehensive Review.
    Wang SM; Han C; Bahk WM; Lee SJ; Patkar AA; Masand PS; Pae CU
    Chonnam Med J; 2018 May; 54(2):101-112. PubMed ID: 29854675
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Other Antidepressants.
    Schwasinger-Schmidt TE; Macaluso M
    Handb Exp Pharmacol; 2019; 250():325-355. PubMed ID: 30194544
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Risk of fractures with selective serotonin-reuptake inhibitors or tricyclic antidepressants.
    Ginzburg R; Rosero E
    Ann Pharmacother; 2009 Jan; 43(1):98-103. PubMed ID: 19116378
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Safety reporting and adverse-event profile of mirtazapine described in randomized controlled trials in comparison with other classes of antidepressants in the acute-phase treatment of adults with depression: systematic review and meta-analysis.
    Watanabe N; Omori IM; Nakagawa A; Cipriani A; Barbui C; McGuire H; Churchill R; Furukawa TA;
    CNS Drugs; 2010 Jan; 24(1):35-53. PubMed ID: 20030418
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Use of selective serotonin-reuptake inhibitors or tricyclic antidepressants and risk of hip fractures in elderly people.
    Liu B; Anderson G; Mittmann N; To T; Axcell T; Shear N
    Lancet; 1998 May; 351(9112):1303-7. PubMed ID: 9643791
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Developments in the drug treatment of panic disorder: what is the place of the selective serotonin reuptake inhibitors?
    Westenberg HG
    J Affect Disord; 1996 Sep; 40(1-2):85-93. PubMed ID: 8882918
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Comparison of compliance between serotonin reuptake inhibitors and tricyclic antidepressants: a meta-analysis.
    Montgomery SA; Kasper S
    Int Clin Psychopharmacol; 1995 Jan; 9 Suppl 4():33-40. PubMed ID: 7622822
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Antidepressant use patterns in clinical practices: comparisons among tricyclic antidepressants and selective serotonin reuptake inhibitors.
    Donoghue J
    Acta Psychiatr Scand Suppl; 2000; 403():57-61. PubMed ID: 11019936
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Efficacy and tolerability of selective serotonin reuptake inhibitors compared with tricyclic antidepressants in depression treated in primary care: systematic review and meta-analysis.
    MacGillivray S; Arroll B; Hatcher S; Ogston S; Reid I; Sullivan F; Williams B; Crombie I
    BMJ; 2003 May; 326(7397):1014. PubMed ID: 12742924
    [TBL] [Abstract][Full Text] [Related]  

  • 50. The safety and tolerability of citalopram.
    Muldoon C
    Int Clin Psychopharmacol; 1996 Mar; 11 Suppl 1():35-40. PubMed ID: 8732443
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Selective serotonin reuptake inhibitors and tricyclic antidepressants in the acute treatment of chronic depression and dysthymia: a systematic review and meta-analysis.
    von Wolff A; Hölzel LP; Westphal A; Härter M; Kriston L
    J Affect Disord; 2013 Jan; 144(1-2):7-15. PubMed ID: 22963896
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Association of Selective Serotonin Reuptake Inhibitors With the Risk for Spontaneous Intracranial Hemorrhage.
    Renoux C; Vahey S; Dell'Aniello S; Boivin JF
    JAMA Neurol; 2017 Feb; 74(2):173-180. PubMed ID: 27918771
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Are SSRIs a cost-effective alternative to tricyclics?
    Hotopf M; Lewis G; Normand C
    Br J Psychiatry; 1996 Apr; 168(4):404-9. PubMed ID: 8730935
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Weight gain and antidepressants.
    Fava M
    J Clin Psychiatry; 2000; 61 Suppl 11():37-41. PubMed ID: 10926053
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Citalopram in the treatment of depression.
    Parker NG; Brown CS
    Ann Pharmacother; 2000 Jun; 34(6):761-71. PubMed ID: 10860138
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Comparative studies with milnacipran and tricyclic antidepressants in the treatment of patients with major depression: a summary of clinical trial results.
    Kasper S; Pletan Y; Solles A; Tournoux A
    Int Clin Psychopharmacol; 1996 Sep; 11 Suppl 4():35-9. PubMed ID: 8923125
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Milnacipran, a new serotonin and noradrenaline reuptake inhibitor: an overview of its antidepressant activity and clinical tolerability.
    Puech A; Montgomery SA; Prost JF; Solles A; Briley M
    Int Clin Psychopharmacol; 1997 Mar; 12(2):99-108. PubMed ID: 9219045
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Cardiac disorders and antidepressant medications.
    Murray JB
    J Psychol; 2000 Mar; 134(2):162-8. PubMed ID: 10766108
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Antidepressants and suicide risk in the United States, 1985-1999.
    Grunebaum MF; Ellis SP; Li S; Oquendo MA; Mann JJ
    J Clin Psychiatry; 2004 Nov; 65(11):1456-62. PubMed ID: 15554756
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Cardiovascular effects of antidepressant drugs: updated.
    Glassman AH
    J Clin Psychiatry; 1998; 59 Suppl 15():13-8. PubMed ID: 9786306
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.